Zenas Biopharma Inc Revenue per Employee (ZBIO), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Zenas Biopharma Inc   (NASDAQ: ZBIO)
 

Zenas Biopharma Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Zenas Biopharma Inc 's Revenue per employee grew on a trailing twelve month basis to $ 5,988, above the company average.
Within the Healthcare sector Zenas Biopharma Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Zenas Biopharma Inc has 167 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZBIO Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change - - - - -
Sales per Employee (TTM) $ 5,988 - 59,880 89,820 89,820
ZBIO's Total Ranking # # # # #
Seq. Revenue Change - - - - -

ZBIO Company Profile >> Back to ZBIO Efficiency Comparisons >> Compare ZBIO Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 0 $ 0 $ 0
 



Financial Statements
Zenas Biopharma Inc 's Revenue MRQ $ 1 Millions Visit ZBIO's Income Statement
Zenas Biopharma Inc 's Revenues TTM $ 1 Millions Visit ZBIO's aggregate revenue growth
What are ZBIO's Sales? Visit ZBIO's Sales by Segment




Other Ratios
Zenas Biopharma Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ZBIO's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ZBIO's Competitors
Revenue per Employee for ZBIO's Suppliers
Revenue per Employee for ZBIO's Customers

You may also want to know
ZBIO's Sales Growth Rates ZBIO's Pe Price to earnings ratio ZBIO's Receivables Turnover Ratio ZBIO's Stock Quote
ZBIO's Net Income Growth Rates ZBIO's Ps Price to Sales ratio ZBIO's Sales per Employee ZBIO's Asset Turnover Ratio
ZBIO's Net Margin ZBIO's Pb Price to Book ratio ZBIO's Financial Strength Ratios ZBIO's Dividend Payout Ratio
Date modified: 2026-09-26T07:43:05+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Pulse Biosciences Inc   10,215.52 $ 1.185  Million 116 
Roivant Sciences Ltd   10,042.67 $ 7.532  Million 750 
Skinvisible Inc   10,000.00 $ 0.020  Million 2 
Aclarion Inc   7,615.27 $ 0.084  Million 11 
Lightwave Logic Inc   7,360.32 $ 0.250  Million 34 
Co diagnostics Inc   6,272.93 $ 0.721  Million 115 
Prokidney Corp   3,541.13 $ 0.818  Million 231 
Pavmed Inc   3,073.17 $ 0.126  Million 41 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.